Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Bile Acid Metabolism in Liver Pathobiology

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Bile acids facilitate intestinal nutrient absorption and biliary cholesterol secretion to maintain bile acid homeostasis, which is essential for protecting liver and other tissues and cells from cholesterol and bile acid toxicity. Bile acid metabolism is tightly regulated by bile acid synthesis in the liver and bile acid biotransformation in the intestine. Bile acids are endogenous ligands that activate a complex network of nuclear receptor farnesoid X receptor and membrane G protein-coupled bile acid receptor-1 to regulate hepatic lipid and glucose metabolic homeostasis and energy metabolism. The gut-to-liver axis plays a critical role in the regulation of enterohepatic circulation of bile acids, bile acid pool size, and bile acid composition. Bile acids control gut bacteria overgrowth, and gut bacteria metabolize bile acids to regulate host metabolism. Alteration of bile acid metabolism by high-fat diets, sleep disruption, alcohol, and drugs reshapes gut microbiome and causes dysbiosis, obesity, and metabolic disorders. Gender differences in bile acid metabolism, FXR signaling, and gut microbiota have been linked to higher prevalence of fatty liver disease and hepatocellular carcinoma in males. Alteration of bile acid homeostasis contributes to cholestatic liver diseases, inflammatory diseases in the digestive system, obesity, and diabetes. Bile acid-activated receptors are potential therapeutic targets for developing drugs to treat metabolic disorders.

          Related collections

          Author and article information

          Journal
          Gene Expr
          GE
          Gene Expression
          Cognizant Communication Corporation (Elmsford, NY )
          1052-2166
          1555-3884
          2018
          18 May 2018
          : 18
          : 2
          : 71-87
          Affiliations
          [1] Department of Integrative Medical Sciences, Northeast Ohio Medical University , Rootstown, OH, USA
          Author notes
          Address correspondence to John Y. L. Chiang, Ph.D., Department of Integrative Medical Sciences, Northeast Ohio Medical University, 4209 State Route 44, Rootstown, OH 44272, USA. Tel: 330-325-6694; E-mail: jchiang@ 123456neomed.edu
          Article
          PMC5954621 PMC5954621 5954621 GE379
          10.3727/105221618X15156018385515
          5954621
          29325602
          d41e141a-5ca1-4fb5-bcd6-082682c304a5
          Copyright © 2018 Cognizant, LLC.
          History
          Page count
          Figures: 6, Tables: 0, References: 142, Pages: 17
          Categories
          Invited Review

          Farnesoid X receptor (FXR),Bile acid synthesis,Metabolic regulation,Nuclear receptor,Takeda G protein receptor 5 (TGR5)

          Comments

          Comment on this article